These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33131747)

  • 21. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.
    Fan M; Choi YJ; Tang Y; Bae SM; Yang HP; Kim EK
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31717842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Omics Approach Reveals Dysregulation of Protein Phosphorylation Correlated with Lipid Metabolism in Mouse Non-Alcoholic Fatty Liver.
    Kim SQ; Mohallem R; Franco J; Buhman KK; Kim KH; Aryal UK
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untargeted metabolomics reveals the role of AQP9 in nonalcoholic fatty liver disease in a mice model.
    Cheng Q; Zhang J; Fang J; Ding H; Xu Y; Lu X; Zhang W
    Int J Biol Macromol; 2022 Oct; 219():864-875. PubMed ID: 35961555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial metabolomic profiling for elucidating the alleviating potential of
    Yang XX; Wei JD; Mu JK; Liu X; Li FJ; Li YQ; Gu W; Li JP; Yu J
    World J Gastroenterol; 2019 Nov; 25(43):6404-6415. PubMed ID: 31798277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.
    Wang Y; Zhao H; Yang L; Zhang H; Yu X; Fei W; Zhen Y; Gao Z; Chen S; Ren L
    Bioengineered; 2022 Mar; 13(3):6750-6766. PubMed ID: 35246007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism.
    De Nardo W; Miotto PM; Bayliss J; Nie S; Keenan SN; Montgomery MK; Watt MJ
    Mol Metab; 2022 Jun; 60():101491. PubMed ID: 35381388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
    Zheng F; Cai Y
    Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease.
    Liu J; Li D; Dun Y; Li H; Ripley-Gonzalez JW; Zhang J; Qiu L; You B; Liu S
    Life Sci; 2022 Nov; 308():120949. PubMed ID: 36096243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 34. Study on the mechanism of vitamin E alleviating non-alcoholic fatty liver function based on non-targeted metabolomics analysis in rats.
    Zhao B; Zhang J; Zhao K; Zhao W; Shi Y; Liu J; Zeng L; Wang C; Zeng X; Shi J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4299-4307. PubMed ID: 38091076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway.
    Sun L; Zhang S; Yu C; Pan Z; Liu Y; Zhao J; Wang X; Yun F; Zhao H; Yan S; Yuan Y; Wang D; Ding X; Liu G; Li W; Zhao X; Liu Z; Li Y
    Am J Physiol Endocrinol Metab; 2015 Dec; 309(11):E925-35. PubMed ID: 26442880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS.
    Yan X; Li L; Liu P; Xu J; Wang Z; Ding L; Yang L
    J Pharm Biomed Anal; 2022 Mar; 211():114620. PubMed ID: 35124446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Huang Zhen mycoplasm polysaccharides mitigate nonalcoholic fatty liver disease induced by a high-fat diet in mice: Evidence from hepatic metabolomics.
    Wu Y; Xu F; Song Z; Jiang H; Li S; Huo G; Hua C
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132889. PubMed ID: 38844288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Untargeted metabonomics reveals intervention effects of chicory polysaccharide in a rat model of non-alcoholic fatty liver disease.
    Zhu H; Wang Z; Wu Y; Jiang H; Zhou F; Xie X; Wang R; Hua C
    Int J Biol Macromol; 2019 May; 128():363-375. PubMed ID: 30690116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.